SI Xiaoxue,HAN Xue,ZHAO Shanshan.Clinical Efficacy of Huangqin Beimutang in Treatment of Chronic Rhinosinusitis in Children[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(10):160-165.
SI Xiaoxue,HAN Xue,ZHAO Shanshan.Clinical Efficacy of Huangqin Beimutang in Treatment of Chronic Rhinosinusitis in Children[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(10):160-165. DOI: 10.13422/j.cnki.syfjx.20231697.
Clinical Efficacy of Huangqin Beimutang in Treatment of Chronic Rhinosinusitis in Children
To observe the clinical efficacy of Huangqin Beimutang on chronic rhinosinusitis in children.
Method
2
A randomized controlled trial (RCT) was conducted on 70 children who met the criteria for chronic rhinosinusitis, with 35 cases in the Chinese medicine group and 35 cases in the western medicine group. In the western medicine group,children received mometasone furoate nasal spray,one spray per nostril,once a day for two weeks, and also received a small dose of azithromycin suspension at 4 mg·kg
-1
·d
-1
,once a day,3 days a week for 2 weeks. The children in the Chinese medicine group were treated with oral Huangqin Beimutang,one dose per day for 2 weeks. Before and after treatment,the scores of primary symptoms and signs of traditional Chinese medicine (TCM),visual analogue scale (VAS) symptom scores,sinus computed tomography (CT) efficacy scores,and clinical efficacy of TCM syndromes in the two groups were evaluated,and the occurrence of adverse events was recorded.
Result
2
The total effective rate of clinical efficacy of TCM syndrome in the Chinese medicine group was 88.57% (31/35), which was higher than 71.43% (25/35) in the western medicine group(
χ
2
=8.458,
P
<
0.05). The VAS scores, scores of TCM primary symptoms of nasal obstruction and runny nose, and physical sign scores in both groups were lower than those after treatment (
P
<
0.01). The above indicators in the Chinese medicine group were superior to those in the western medicine group after treatment (
P
<
0.05,
P
<
0.01). Compared with the conditions before treatment, there was no significant improvement in headache in the western medicine group, while the headache score in the Chinese medicine group decreased after treatment (
P
<
0.01). The CT scores of the two groups showed a downward trend, but the difference was not statistically significant. There were no adverse reactions during treatment in both groups.
Conclusion
2
Huangqin Beimutang can effectively improve the clinical symptoms of patients with chronic rhinosinusitis, and it is safe and effective.
MATUCCI A,BORMIOLI S,NENCINI F,et al.Asthma and chronic rhinosinusitis:How similar are they in pathogenesis and treatment responses?[J].Int J Mol Sci,2021,22(7):3340.
Clinical Observation of Modified Yinqiaosan Combined with Antibiotics in Treatment of Acute Tonsillitis in Children with Wind-heat Invading Lung Syndrome
Effect of Maxing Shigantang and Supplemented Guominjian Decoction on Symptoms and Inflammatory Cytokine Levels in Induced Sputum of Children with Cough Variant Asthma
Clinical Evidence of Chinese Patent Medicines in Treatment of Respiratory Diseases in Children: A Scoping Review
Sequential Treatment with Syndrome Differentiation on Children's Refractory Nephrotic Syndrome with Yiqi Huayu Qingre Prescription
Multicenter Randomized Controlled Clinical Trial of Longmu Zhuanggu Granule in Treatment of Children Recurrent Respiratory Infection with Lung-Spleen Qi Deficiency Syndrome
Related Author
QIAO Jinghua
YU Linlin
JING Xiaoping
DONG Xiaoyan
GU Mingda
QIU Zhikai
WANG Chunlian
YOU Shijun
Related Institution
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Children's Hospital of Shanghai, Children's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Jilin Academy of Traditional Chinese Medicine
Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences
China Center for Evidence Based Traditional Chinese Medicine